Q3 Report: Global Trends in Biopharma Transactions

Each quarter our team at Locust Walk compiles key statistics and trends on strategic transactions and financings. Our Q3 2020 Report: Global Trends in Biopharma Transactions applies the latest data to analyze current activities in the life science deal landscape.   ...

Biopharma’s COVID Capital Comeback – A Whitepaper

What a difference a few months can make – especially during a pandemic. Heading into 2020, biopharma looked like it would be typecast in its typical election year role: the big business scapegoat for everything that’s wrong in health care. There had been the usual big...

Panel Recording: The Unexpected IPO Boom in Biopharma in Q2

Locust Walk partnered with Applied Molecular Transport, Forma Therapeutics, and Goodwin for a live panel on Thursday, July 23rd. Q2 saw a boom in IPOs, while many biopharma companies continue to seek capital in both public and private markets, including multiple...